The global nutraceutical CDMO market is poised for remarkable expansion, with a projected year-over-year growth rate of 6.8%. Recent forecasts indicate that the market’s value is anticipated to soar from USD 35,730.8 million in 2024 to an impressive USD 61,655.3 million by 2034. This growth trajectory is propelled by a consistent surge in demand, estimated to rise at a compound annual growth rate (CAGR) of 5.6% throughout the forecast period.
Several pivotal factors are fueling this surge in the global nutraceutical CDMO market. Foremost among them is the escalating demand for nutraceuticals, reflecting evolving consumer preferences towards health and wellness. Additionally, there is a notable trend towards outsourcing within the industry, as companies seek specialized expertise and cost-saving advantages offered by CDMOs. Furthermore, the growing popularity of personalized nutrition is driving nutraceutical companies to seek streamlined processes and innovative solutions, further underscoring the significance of CDMOs in the market landscape.
Request A Sample Research Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-18770
As nutraceutical companies navigate an increasingly complex and competitive market environment, they are recognizing the strategic value of partnering with CDMOs. These partnerships provide access to cutting-edge technology, regulatory compliance, and operational efficiency, enabling companies to focus on core competencies while accelerating product development and market entry.
The projected growth of the global nutraceutical CDMO market underscores the industry’s resilience and potential for innovation. As demand continues to surge and market dynamics evolve, collaboration between nutraceutical companies and CDMOs will remain instrumental in driving forward progress and meeting the diverse needs of consumers worldwide.
Key Takeaways from the Market Study:
- The global market for nutraceutical CDMOs is set to reach a valuation of USD 61,655.3 million in 2034.
- By dosage form, the tablets & capsules segment held a share value of 1% in 2023.
- By services, the manufacturing and packaging segment accounted for a market value share of 1% in 2023.
- By company size, the mid-sized companies segment is poised to grow at 7% CAGR.
- North America accounted for a substantial value share of 5% in 2023.
- Demand in China is projected to increase at 4% CAGR through 2034.
“Increasing demand for nutraceutical products globally and rising interest in personalized nutrition are expected to play key roles in boosting the nutraceutical CDMO market growth through 2034,” says an analyst of Future Market Insights (FMI).
Customization with Our Report: https://www.futuremarketinsights.com/customization-available/rep-gb-18770
Who is Winning?
Nutraceutical CDMOs are collaborating with brands to share expertise in personalized product development. By working closely with clients, CDMOs can contribute insights into ingredient selection, dosages, and formulation strategies that align with the emerging trends in self-care and personalization. Several companies are also employing strategies like acquisitions and partnerships to stay ahead of the competition.
Recent Developments:
- In June 2022, Best Formulations, a leading company specializing in the production of nutraceuticals and dietary supplements, completed the acquisition of Sirio, a global nutraceuticals contract manufacturer renowned for its expertise in the supplement market. The acquisition positions Best Formulations as a more comprehensive and diversified player in the nutraceutical contract manufacturing landscape, poised to deliver a wider range of innovative and high-quality products to clients on a global scale.
- In August 2021, Catalent, Inc. announced the acquisition of Bettera Holdings, LLC, to expand its expertise and offerings in the nutraceuticals sector.
Key Companies Profiled:
- Catalent
- Lonza
- Aenova Group
- Akums Drugs and Pharmaceutical Ltd.
- BASF SE
- Sirio Pharma
- Pharmavite LLC
- Nature’s Products, Inc.
- PLT Health Solutions
- Glanbia Nutritionals
- Recipharm AB
- B&D Nutritional Ingredients
- NutraScience Labs
- Vitakem Nutraceutical Inc.
- Softigel (A division of Procaps Group)
- Iprona AG
- Nutrilo GmbH
- Atlantic Essential Products, Inc.
- ProTec Nutra Ltd.
- Nutraceuticals International Group
Key Market Segments Covered in Nutraceutical CDMO Market Research:
By Dosage Form:
- Tablets & Capsules
- Powder
- Softgel
- Liquid Formulations
- Others (Gummies, Sprays, Sachets, Topical Forms)
By Services:
- Product Formulation and Development
- Manufacturing and Packaging
- Research and Development
- Analytical and Testing Services
- Regulatory Support
By Company Size:
- Small Companies
- Mid-sized Companies
- Large Companies
By Region:
- North America
- Latin America
- East Asia
- South Asia & Pacific
- Western Europe
- Eastern Europe
- Middle East & Africa
A Full Report Overview: https://www.futuremarketinsights.com/checkout/18770
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and market trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
